Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
26
Frequently Asked Questions
What is Market Cap of Mainz Biomed N.V.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Mainz Biomed N.V. market cap is $7.46M.
What is the 52-week high for Mainz Biomed N.V.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Mainz Biomed N.V. 52 week high is $16.04 as of September 07, 2025.
What is the 52-week low for Mainz Biomed N.V.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Mainz Biomed N.V. 52 week low is $1.30 as of September 07, 2025.
What is Mainz Biomed N.V. stock price today?
Mainz Biomed N.V. stock price today is $1.63.
What was Mainz Biomed N.V. stock price yesterday?
Mainz Biomed N.V. stock price yesterday was $1.68.
What is the PE ratio of Mainz Biomed N.V.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Mainz Biomed N.V.’s P/E ratio is -0.02.
What is the Price-to-Book ratio of Mainz Biomed N.V.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Mainz Biomed N.V. P/B ratio is 0.2654.
What is the 50-day moving average of Mainz Biomed N.V.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Mainz Biomed N.V. 50-day moving average is $1.69.
